Reneo Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was USD 8.43 million compared to USD 15.11 million a year ago. Basic loss per share from continuing operations was USD 0.25 compared to USD 0.6 a year ago.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.61 USD | +1.90% | -5.84% | -2.31% |
May. 16 | Reneo Pharmaceuticals Insider Bought Shares Worth $639,578, According to a Recent SEC Filing | MT |
May. 13 | Reneo Pharmaceuticals to Merge With OnKure in All-Stock Deal -- Reneo Shares Rise | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-2.31% | 52.8M | |
+36.26% | 51.51B | |
-6.86% | 39.03B | |
+34.15% | 38.91B | |
-10.62% | 26.68B | |
+11.45% | 26.13B | |
-14.04% | 19.91B | |
+42.83% | 13.71B | |
+30.21% | 12.38B | |
-3.37% | 11.74B |
- Stock Market
- Equities
- RPHM Stock
- News Reneo Pharmaceuticals, Inc.
- Reneo Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024